G 207 (Moexipril and Hydrochlorothiazide 12.5 mg / 7.5 mg)
Pill imprint G 207 has been identified as Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg.
Moexipril is used in the treatment of diabetic kidney disease; left ventricular dysfunction; high blood pressure; heart failure; heart attack and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Moexipril 12.5 mg / 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- G 207
- 12.5 mg / 7.5 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Glenmark Generics Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
hydroxypropyl cellulose (type h)
polyethylene glycol 6000
ferric oxide yellow
Note: Inactive ingredients may vary.
More about moexipril
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 2 Reviews – Add your own review/rating
- Drug class: angiotensin converting enzyme inhibitors
Other brands: Univasc
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.